99% Savings - Buy Just @1 Rs X
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet safe for pregnant women?
Pregnant women can take StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet safely.
Is the use of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet safe during breastfeeding?
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is safe for breastfeeding women.
What is the effect of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet on the Kidneys?
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet rarely harms the kidneys.
What is the effect of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet on the Liver?
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is not harmful for the liver.
What is the effect of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet on the Heart?
There are no any side effects of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet for the heart.
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet unless your doctor advises you to do so -
Is this StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet habit forming or addictive?
StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is not addictive in nature.
Interaction between Food and StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet
Taking StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet
It is difficult to say anything about the effect of StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet and alcohol. No research has been done on this yet.
Yes, StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet might affect hormonal birth control because it can cause decreases in estrogen reabsorption and reduction in the efficacy of combined oral contraceptives (estrogen and progesterone).
Yes, StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as diarrhoea, nausea, and vomiting. If you experience any of the above conditions after taking this medicine then do not hesitate to inform your doctor and follow his/her instructions.
Yes, StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet is an antibiotic. It contains cefotaxime which is a broad spectrum antibiotic that belongs to the class of drugs known as cephalosporins. It is a prescription drug which is used for the prevention and treatment of various bacterial infections.
Take StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet as long as your doctor has prescribed it. Do not take this medicine longer than prescribed to avoid bacterial resistance.
Yes, StayHappi Cefuroxime Axetil + Potassium Clavulanate Tablet can affect hemoglobin, it causes decreased hemoglobin in blood but this occurs rarely. It is a known side effect of this drug. However, the exact cause behind this is unknown.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftin (cefuroxime axetil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 302-312